PATIENT_ID,GENDER,Age_at_IO_start,Smoking_Signature,PACK_YEARS,ALCOHOL_NEVER_EVER,ALCOHOL_DOSE,HPV_Final_2,EBV,AnyVirus,ALLERGIES,AUTOIMMUNE_DISEASES,PRIMARY_TUMOR_SITE,Non_oral_Vs_oral,TUMOR_GRADE,METASTATIC_VS_RECURRENT,METASTATIC_SITE,Number_sites_mets,Sample_ID_selected,IO_DRUG_NAME,IO_DRUG_CLASS,CONCOMITANT_IO,NEUTROPHILS,LYMPHOCYTES,NLR,MONOCYTES,Neut*Mono/Lymp,Platelets,HGB,Albumin,H_index,ECOG,INFECTION_DURING_IO,ANTIBIOTICS,BEST_RESPONSE,Nonresponders_Responders,Clinical_benefit(CR/PR/SD>6m),Progression,PFS,TOXICITY,Time_IO_to_Tox_Months,STEROIDS,Overall_Survival_Event,OS,Disease_Specific_Survival_Event,Disease_Specific_Survival (Months),TUMOR_PURITY_IMPACT,Purity_FACETS,Ploidy_FACETS,dipLogR_FACETS,CnvCnt_FACETS,CVAL_FACETS,Emflag_FACETS,nonsyn.TMB,fga,PDL1 amp,PDL1 del,9q34.3 del,GENE_PANEL,TP53,PIK3CA,TERT promoter,HLALOH,HLAdivA,HLAdivB,HLAdivC,HLAmeanABCdiv,PDL1,del9p,del9q34.3
P-0002745,F,54.47227926,Absent,0,1,1,0,N/A,0,Yes,Present,Oral Cavity,1,Poor,Non-metastatic,N/A,N/A,P-0002745-T01-IM3,Nivolumab,PD-1/PD-L1,,7.8,0.6,13,0.5,6.5,397,11.3,3.5,16.43489254,1-2,No,No,PD,0,0,1,1.379876797,Yes,0.59137577,No,1,2.266940452,1,2.266940452,20,0.26219659,2.384991815,-0.071037393,37,80, Low purity. Calls can be unreliable.,3.3,0.0569,0,0,0,IMPACT341,wt,wt,0,0,NA,NA,NA,NA,wt,0,0
P-0001186,M,69.93292266,Absent,0,1,3,1,N/A,1,No,Absent,Non-oral cavity,0,Poor,Metastatic,Bone/Liver/Lung,3,P-0001186-T01-IM3,Pembrolizumab,PD-1/PD-L1,,3.4,1,3.4,0.5,1.7,301,11.5,4.1,3.605514316,0,Yes,Yes,PD,0,0,1,1.379876797,No,,No,1,5.9137577,1,5.9137577,25,0.230910143,2.234131265,-0.03848063,37,80, Low purity. Calls can be unreliable.,1.1,0.0535,0,0,0,IMPACT341,wt,wt,0,0,NA,NA,NA,NA,wt,0,0
P-0019240,M,58.81451061,Present,15,0,0,0,N/A,0,No,Absent,Oral Cavity,1,Poor,Metastatic,Lung/Brain,2,P-0019240-T01-IM6,Pembrolizumab,PD-1/PD-L1,,10,1,10,0.4,4,160,12,3.6,9.259259259,0,Yes,Yes,PD,0,0,1,1.149897331,No,,Yes,1,3.154004107,1,3.154004107,80,0.742312628,3.422394376,-0.611579067,59,80,OK,1.8,0.5909,0,0,0,IMPACT468,mut,wt,1,0,0,7.640883978,4.82320442,4.154696133,wt,0,0
P-0009188,M,79.69883641,Absent,0,0,0,1,N/A,1,Yes,Absent,Non-oral cavity,0,Poor,Metastatic,Mediastinal Lymph Nodes,1,P-0009188-T01-IM5,DurvalumabTremelimumab,Combo,,3.6,0.8,4.5,0.4,1.8,159,13.1,3.9,3.523194363,0,Yes,Yes,PR,1,1,1,20.27104723,No,,No,0,73.49486653,0,73.49486653,60,0.423439116,2.134937166,-0.04063835,47,80,OK,6.9,0.1152,0,0,0,IMPACT410,wt,wt,0,1,3.20441989,11.9281768,7.193370166,7.44198895,wt,0,0
P-0000621,M,43.80561259,Present,3,1,3,1,N/A,1,No,Absent,Oral Cavity,1,Moderate,Metastatic,Lung,1,P-0000621-T01-IM3,Durvalumab,PD-1/PD-L1,,5.4,0.8,6.75,0.3,2.025,203,14,4.6,3.144409938,1-2,No,No,PD,0,0,1,1.149897331,No,,No,1,7.359342916,1,7.359342916,40,0.490026966,2.626113772,-0.205900828,47,80,OK,4.5,0.1017,0,0,0,IMPACT341,mut,wt,0,0,NA,NA,NA,NA,wt,0,0
P-0006525,F,66.55441478,Present,75,0,0,0,negative,0,Yes,Absent,Non-oral cavity,0,Moderate,Metastatic,Bone,1,P-0006525-T01-IM5,Pembrolizumab,PD-1/PD-L1,,12.1,1.3,9.307692308,0.6,5.584615385,341,10.8,3.5,14.77411477,1-2,Yes,Yes,PD,0,0,1,2.201232033,No,,Yes,1,2.201232033,1,2.201232033,30,0.33550862,1.835696269,0.040322802,42,80,OK,3.9,0.2156,0,0,0,IMPACT410,wt,wt,0,0,0,9.414364641,3.348066298,4.254143646,wt,0,0
P-0010588,F,79.97535934,Absent,0,0,0,0,N/A,0,No,Absent,Oral Cavity,1,Moderate,Non-metastatic,N/A,N/A,P-0010588-T01-IM5,Nivolumab,PD-1/PD-L1,,4.9,0.8,6.125,0.4,2.45,399,10.3,3.1,7.673034764,1-2,Yes,Yes,SD,0,0,1,4.369609856,No,,No,1,4.369609856,1,4.369609856,20,0.334209588,3.137080978,-0.250975737,52,80,OK,5.9,0.046,0,0,0,IMPACT410,mut,wt,1,0,6.425414365,4.70718232,6.491712707,5.874769797,wt,0,0
P-0008169,F,52.66255989,Present,35,1,3,0,N/A,0,No,Absent,Non-oral cavity,0,Moderate,Metastatic,Lung,1,P-0008169-T01-IM5,Nivolumab,PD-1/PD-L1,Urelumab,4.5,0.5,9,0.5,4.5,217,10.6,4.2,10.10781671,0,No,No,PD,0,0,1,1.609856263,Yes,0.985626283,Yes,1,5.716632444,1,5.716632444,50,0.351815962,2.353382312,-0.087004866,36,80,OK,6.9,0.2087,0,0,0,IMPACT410,mut,mut,0,0,10.60773481,14.09944751,3.116022099,9.274401473,wt,0,0
P-0013652,M,59.4770705,Present,15,1,3,0,N/A,0,No,Absent,Oral Cavity,1,Moderate,Non-metastatic,N/A,N/A,P-0013652-T01-IM5,Pembrolizumab,PD-1/PD-L1,,18.9,1.5,12.6,1.2,15.12,495,8.9,3.3,51.48110317,1-2,Yes,Yes,PD,0,0,1,2.102669405,No,,No,1,2.95687885,1,2.95687885,60,0.395639635,2.178630295,-0.050099898,26,80,OK,9.8,0.095,0,0,0,IMPACT410,wt,wt,1,0,7.458563536,6.723756906,5.624309392,6.602209945,wt,0,0
P-0009588,M,35.21149897,Absent,0,0,0,0,positive,1,Yes,Absent,Non-oral cavity,0,"Non-Keratinizing, Undifferentiated",Metastatic,Lung/Mediastinal and Abdominal Lymph Nodes,3,P-0009588-T01-IM5,Nivolumab,PD-1/PD-L1,,2.1,0.6,3.5,0.3,1.05,170,11.8,4.5,1.97740113,1-2,No,No,PD,0,0,1,1.839835729,No,,No,1,7.622176591,1,7.622176591,60,0.575563224,1.713501639,0.124139683,36,80,OK,3,0.1495,0,0,0,IMPACT410,wt,wt,0,1,9.309392265,11.08287293,5.883977901,8.758747698,wt,0,0
P-0025373,M,60.22450376,Absent,0,1,2,0,N/A,0,No,Absent,Oral Cavity,1,Moderate,Metastatic,Lung/Brain/Bone,3,P-0025373-T01-IM6,Nivolumab,PD-1/PD-L1,,14.4,0.4,36,0.2,7.2,189,8,2.3,39.13043478,1-2,Yes,Yes,PD,0,0,1,1.609856263,No,,No,1,1.609856263,1,1.609856263,20,,,,,,,12.3,0.0179,0,0,0,IMPACT468,mut,wt,1,0,NA,NA,NA,NA,wt,0,0
P-0016243,M,45.36071184,Absent,0,0,0,1,N/A,1,Yes,Absent,Non-oral cavity,0,Poor,Metastatic,Brain/Leptomeningeal/Lung/Mediastinal Lymph Nodes,4,P-0016243-T04-IM6,Pembrolizumab,PD-1/PD-L1,,7.96,0.23,34.60869565,0.48,16.61217391,225,9.6,4.4,39.32806324,1-2,Yes,Yes,PD,0,0,1,1.80698152,No,,Yes,1,3.154004107,1,3.154004107,1,0.217159635,2.329810673,-0.050760482,28,80, Low purity. Calls can be unreliable.,0,0.0087,0,0,0,IMPACT468,wt,wt,0,0,8.917127072,7.35359116,5.524861878,7.26519337,wt,0,0
P-0005869,M,68.29568789,Present,25,1,,1,N/A,1,Yes,Absent,Non-oral cavity,0,Poor,Metastatic,Lung/Liver/Mediastinal Lymph Nodes/Wall chest/Diafragm,5,P-0005869-T01-IM5,Nivolumab,PD-1/PD-L1,Lirilumab  ,10.3,1,10.3,1,10.3,382,11.2,3.9,23.58058608,0,Yes,Yes,PD,0,0,1,1.577002053,Yes,0,Yes,1,7.030800821,1,7.030800821,30,0.501438837,1.827729143,0.063698114,37,80,OK,2,0.2149,0,0,0,IMPACT410,wt,wt,0,1,4.215469613,7.657458564,6.364640884,6.079189687,wt,0,0
P-0029685,M,56.79397673,Present,25,1,3,1,N/A,1,Yes,Absent,Non-oral cavity,0,Unknown,Metastatic,Lung/Bone,2,P-0029685-T01-IM6,Nivolumab,PD-1/PD-L1,ICOS agonist,5,0.5,10,0.9,9,198,13.2,4.2,16.23376623,0,No,No,PD,0,0,1,1.839835729,No,,No,1,20.13963039,1,20.13963039,60,0.8846129,2.031322405,-0.019850057,38,80,OK,10.5,0.1979,0,0,0,IMPACT468,wt,mut,0,1,6.425414365,9.696132597,6.149171271,7.423572744,wt,0,0
P-0010450,M,73.47843943,Absent,0,1,3,0,N/A,0,No,Absent,Non-oral cavity,0,Moderate,Metastatic,Bone/Liver/Adrenal,3,P-0010450-T01-IM5,Pembrolizumab,PD-1/PD-L1,,4.5,1.6,2.8125,0.8,2.25,150,10.4,3.9,5.547337278,1-2,No,No,PR,1,1,1,4.369609856,No,,No,1,14.19301848,1,14.19301848,40,0.702459556,3.45283238,-0.594814128,63,80,OK,8.9,0.3939,0,0,0,IMPACT410,mut,mut,0,0,5.121546961,13.3038674,3.348066298,7.257826888,wt,0,0
P-0010104,M,33.91101985,Present,2,0,0,0,N/A,0,No,Present,Non-oral cavity,0,Poor,Metastatic,Cavernous sinus,1,P-0010104-T01-IM5,Nivolumab,PD-1/PD-L1,,8.7,0.3,29,0.4,11.6,190,11,3.1,34.01759531,0,Yes,Yes,PD,0,0,1,1.18275154,No,,Yes,1,2.98973306,1,2.98973306,40,,,,,,,4.9,0.3932,0,0,0,IMPACT410,mut,wt,0,0,NA,NA,NA,NA,wt,0,0
P-0014022,M,68.71457906,Present,9,1,1,1,N/A,1,No,Absent,Non-oral cavity,0,Poor,Metastatic,Lung,1,P-0014022-T01-IM5,Nivolumab,PD-1/PD-L1,Varililumab ,4.3,1,4.3,0.6,2.58,190,13.1,4.3,4.580152672,0,Yes,Yes,PR,1,1,1,7.260780287,Yes,4.402464066,Yes,1,8.640657084,1,8.640657084,40,0.339024335,2.128985699,-0.031204112,36,80,OK,0,0.0955,0,0,0,IMPACT410,wt,wt,0,0,0,0,0,0,wt,0,0
P-0020846,M,61.724846,Present,22,,,0,N/A,0,Yes,Present,Oral Cavity,1,Moderate,Metastatic,Bone/Lung/Mediastinal Lymph Nodes,3,P-0020846-T01-IM6,Nivolumab,PD-1/PD-L1,,9.37,0.71,13.1971831,1.55,20.4556338,288,9.9,3.5,59.03501819,1-2,No,No,PD,0,0,1,2.036960986,Yes,2.036960986,Yes,1,2.924024641,1,2.924024641,30,,2,-0.052182613,23,80, Insufficient information to estimate purity. Likely diplod or purity too low.,4.4,0.0009,0,0,0,IMPACT468,wt,wt,1,0,7.602209945,6.79558011,4.386740331,6.261510129,wt,0,0
P-0016191,M,77.56605065,Present,3,0,0,0,N/A,0,Yes,Absent,Oral Cavity,1,Moderate,Non-metastatic,N/A,N/A,P-0016191-T01-IM6,Pembrolizumab,PD-1/PD-L1,,11,0.6,18.33333333,0.9,16.5,495,9.2,3.2,56.04619565,1-2,Yes,Yes,PD,0,0,1,1.018480493,No,,No,1,13.33880903,1,13.33880903,30,0.286275737,2.208068945,-0.042339722,28,80, Low purity. Calls can be unreliable.,8.8,0.0149,0,0,0,IMPACT468,mut,mut,1,0,12.53038674,5.447513812,0,5.992633517,wt,0,0
P-0014465,M,34.45311431,Absent,0,1,3,0,N/A,0,Yes,Absent,Oral Cavity,1,Moderate,Non-metastatic,N/A,N/A,P-0014465-T01-IM6,Nivolumab,PD-1/PD-L1,Varililumab ,7.5,0.6,12.5,0.9,11.25,405,12.9,4,21.80232558,0,Yes,Yes,PD,0,0,1,1.675564682,No,,No,0,6.209445585,0,6.209445585,50,0.538435104,1.898105467,0.040128669,54,80,OK,8.8,0.2332,0,0,0,IMPACT468,mut,wt,1,1,4.674033149,0,0,1.55801105,wt,0,0
P-0014015,M,66.74058864,Present,86,1,1,0,N/A,0,Yes,Absent,Non-oral cavity,0,Moderate,Metastatic,Lung,1,P-0014015-T01-IM5,Nivolumab,PD-1/PD-L1,,3,0.6,5,0.4,2,186,11.3,4.2,4.214075011,1-2,No,No,PD,0,0,1,1.642710472,No,,No,1,47.37577002,1,47.37577002,20,0.585283611,3.874773876,-0.630999214,94,80,OK,9.8,0.5513,0,0,0,IMPACT410,mut,wt,0,0,2.817679558,9.243093923,4.486187845,5.515653775,wt,0,0
P-0014965,M,53.33880903,Absent,0,0,0,1,N/A,1,No,Absent,Non-oral cavity,0,Poor,Metastatic,Lung,1,P-0014965-T01-IM6,Nivolumab,PD-1/PD-L1,,4.1,0.7,5.857142857,0.5,2.928571429,282,12.2,3.9,6.155047139,0,No,No,SD,0,0,1,5.552361396,No,,No,1,15.17864476,1,15.17864476,50,0.652843925,2.103964861,-0.048147464,30,80,OK,1.8,0.1171,0,0,0,IMPACT468,wt,wt,0,0,8.972375691,5.430939227,3.685082873,6.02946593,wt,0,0
P-0016210,M,73.01848049,Present,50,,,1,N/A,1,No,Absent,Non-oral cavity,0,Poor,Metastatic,Lymph Node Mediastinal,1,P-0016210-T01-IM6,Nivolumab,PD-1/PD-L1,,4.1,0.9,4.555555556,0.6,2.733333333,292,13.9,4,4.916067146,0,No,No,PR,1,1,0,56.11498973,Yes,3.745379877,Yes,0,56.11498973,0,56.11498973,20,0.515322778,3.196181797,-0.387593997,52,80,OK,4.4,0.5736,0,0,0,IMPACT468,wt,wt,0,1,10.94475138,8.104972376,4.607734807,7.885819521,wt,0,0
P-0025891,M,83.58110883,Present,12,0,0,1,N/A,1,No,Absent,Non-oral cavity,0,Poor,Metastatic,Lung/Liver/Mediastinal LN,3,P-0025891-T01-IM6,Nivolumab,PD-1/PD-L1,,3.5,0.9,3.888888889,0.6,2.333333333,165,10.1,4.4,5.250525053,0,Yes,Yes,PR,1,1,1,16.6899384,No,,Yes,1,36.23819302,1,36.23819302,60,,,,,,,8.8,0.1839,0,0,0,IMPACT468,wt,wt,1,0,NA,NA,NA,NA,wt,0,0
P-0017508,F,68.07939767,Present,1,0,0,0,N/A,0,Yes,Absent,Oral Cavity,1,Poor,Non-metastatic,N/A,N/A,P-0017508-T01-IM6,Pembrolizumab,PD-1/PD-L1,,9.9,0.5,19.8,0.7,13.86,371,9.8,3.4,41.59663866,1-2,No,No,PD,0,0,1,1.511293634,No,,No,1,1.511293634,1,1.511293634,40,0.431067929,2.09606735,-0.029567063,35,80,OK,5.3,0.2276,0,0,0,IMPACT468,mut,wt,1,0,3.779005525,5.563535912,0,3.114180479,wt,0,0
P-0026282,M,66.30800821,Present,80,1,3,0,N/A,0,Yes,Present,Non-oral cavity,0,Poor,Non-metastatic,N/A,N/A,P-0026282-T01-IM6,Nivolumab,PD-1/PD-L1,,20.3,0.5,40.6,1.2,48.72,458,8.1,2.1,286.4197531,1-2,Yes,Yes,SD,0,0,1,4.566735113,No,,Yes,1,5.815195072,1,5.815195072,40,,,,,,,2.6,0.1168,0,0,0,IMPACT468,mut,wt,0,0,NA,NA,NA,NA,wt,0,0
P-0020649,M,63.32922656,Present,50,1,,1,N/A,1,No,Absent,Non-oral cavity,0,Moderate,Metastatic,Mediastinal and Axillar Lymph Nodes,2,P-0020649-T01-IM6,Nivolumab,PD-1/PD-L1,,3.43,1.16,2.956896552,0.47,1.389741379,228,12.8,3.6,3.015931813,1-2,No,No,PR,1,1,1,13.63449692,Yes,8.27926078,No,1,32.55852156,1,32.55852156,60,0.847845534,2.32345683,-0.185385416,38,80,OK,1.8,0.3508,0,0,0,IMPACT468,wt,wt,0,1,8.624309392,10.36464088,6.397790055,8.462246777,wt,0,0
P-0025656,M,63.52635181,Present,15,,,1,negative,1,Yes,Absent,Non-oral cavity,0,Poor,Metastatic,Bone,1,P-0025656-T01-IM6,Pembrolizumab,PD-1/PD-L1,,4.3,0.7,6.142857143,0.8,4.914285714,449,8,3.4,18.06722689,1-2,No,No,PD,0,0,1,2.234086242,No,,No,1,9.46201232,1,9.46201232,40,0.444367001,2.86563736,-0.253783994,27,80,OK,17.6,0.2718,0,0,0,IMPACT468,wt,wt,0,1,1.077348066,9.508287293,0,3.52854512,wt,0,0
P-0024866,M,67.35934292,Present,5,0,0,1,N/A,1,No,Absent,Non-oral cavity,0,Poor,Non-metastatic,N/A,N/A,P-0024866-T01-IM6,Pembrolizumab,PD-1/PD-L1,,5.9,0.8,7.375,0.5,3.6875,285,10.8,3.4,10.04221133,1-2,Yes,Yes,CR,1,1,0,44.91170431,No,,Yes,0,45.8973306,0,44.91170431,60,,,,,,,59.7,0.225,0,0,0,IMPACT468,wt,mut,1,0,NA,NA,NA,NA,wt,0,0
P-0025544,M,50.95140315,Absent,0,0,0,0,N/A,0,No,Absent,Oral Cavity,1,Moderate,Metastatic,Muscle/Bone/Lung,3,P-0025544-T01-IM6,Nivolumab,PD-1/PD-L1,,4.8,0.5,9.6,0.4,3.84,198,12,3.9,8.205128205,0,Yes,Yes,SD,0,0,1,5.552361396,No,,No,1,22.47227926,1,22.47227926,30,0.483699275,2.541046175,-0.177409901,44,80,OK,7.9,0.2052,0,0,0,IMPACT468,mut,wt,1,1,10.50276243,3.674033149,3.116022099,5.76427256,wt,0,0